RAJWINDER KAUR: Open Payments
NPI 1275018681 · ROSAMOND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$166 in 3 payments from 3 companies in 2025. Trend: 2023 $101 · 2024 $0 · 2025 $166
Food & beverage: $166
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $122 |
| Insmed, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $16 |
Products named: NUCALA, Arikayce, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
